EuroLand Corporate initiates its coverage of Visiomed Group shares at Buy, and sets its target price at 0.80E for this "new hyper-growth group", underlines the analyst.

"Whether through pioneering solutions or innovative technological advances, Visiomed brings value through its service and product offerings", continues the broker.

Given its 'structurally buoyant' market, 'genuine capacity for innovation and proven business model', Euroland considers Visiomed Group to be 'very well positioned to combine growth and profitability in the years ahead'.

He adds: 'by 2026, the Group should have sales of 30.9 ME, with a current operating margin of 45.6% on its existing activities'.

'We are confident about Visiomed Group's positioning and its prospects in the short, medium and long term', concludes the analyst.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.